Stage III (Unresectable) or Stage IV Advanced Melanoma
1 clinical trials · Condition
◉ Watch Stage III (Unresectable) or Stage IV Advanced Melanoma
| Record | Firm | Date |
|---|---|---|
| Expanded Access Program With Nivolumab to Treat Melanoma (NCT02142218) | Bristol-Myers Squibb | 2014-06-01 |
Track Stage III (Unresectable) or Stage IV Advanced Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.